基于液相质谱的单克隆抗体全长 De Novo 测序分析测试服务是借助全新一代抗体鉴定平台提供的一项专业分析服务。该服务的核心技术源于基于质谱数据的从头测序算法以及蛋白质谱数据分析软件，整合了目前世界上最先进的液相质谱技术以及质谱数据分析技术。

我们提供整套抗体全长蛋白测序分析测试服务，从实验到数据解析到最终报告，您只需提供不少于200 µg的纯蛋白 (纯度要求≥90%)，即可获取关于此样品的全长蛋白序列准确信息。

样品要求：纯度>90%，样品量>200 µg；IgG单抗，其他类型请提前告知；物种（人源、鼠源为常规物种，其他物种请提前告知），样品中其他杂质可能成分及比例，参考序列 (如有)

服务周期：4-6 周

单克隆抗体全长 De Novo 测序分析测试服务工作流程

分析测试服务报告 (涵盖，但不限于以下内容)

1. 抗体样品描述

2. 各种缩写说明

3. 序列覆盖度

4. 详细结果报告：

其余内容可增值定制，如N-糖谱、轻重链可变区PTM修饰分析等

参考文献：

1.   Automated De novo Protein Sequencing of Monoclonal Antibodies. 26, 1336–1338 (2008).
2.   Abstracts, P. Micro-scale Sample Preparation for C-terminal Protein Characterization by Mass Spectrometry Using Combined Liquid- and Solid Phase Derivatization David Hawke 1 ,. 24, (2013).
3.   Bagal, D., Kast, E. & Cao, P. Rapid Distinction of Leucine and Isoleucine in Monoclonal Antibodies Using Nanoflow LCMSn. Anal. Chem. 89, 720–727 (2017).
4.   Bandeira, N., Clauser, K. R. & Pevzner, P. A. Shotgun protein sequencing: Assembly of peptide tandem mass spectra from mixtures of modified proteins. Mol. Cell. Proteomics 6, 1123–1134 (2007).
5.   Bogdanoff, W. A. et al. De novo sequencing and resurrection of a human astrovirus-neutralizing antibody. ACS Infect. Dis. 2, 313–321 (2016).
6.   Castellana, N. E. et al. Resurrection of a clinical antibody: Template proteogenomic de novo proteomic sequencing and reverse engineering of an anti-lymphotoxin-?? antibody. Proteomics 11, 395–405 (2011).
7.   Castellana, N. E., Pham, V., Arnott, D., Lill, J. R. & Bafna, V. Template Proteogenomics : Sequencing Whole Proteins Using an Imperfect Database * □. 1260–1270 (2010) doi:10.1074/mcp.M900504-MCP200.
8.   Dasari, S. et al. Proteomic detection of immunoglobulin light chain variable region peptides from amyloidosis patient biopsies. J. Proteome Res. 14, 1957–1967 (2015).
9.   Fan, C. Y., Huang, S. Y., Chou, M. Y. & Lyu, P. C. De novo protein sequencing, humanization and in vitro effects of an antihuman CD34 mouse monoclonal antibody. Biochem. Biophys. Reports 9, 51–60 (2017).
10.  Georgiou, G. et al. The promise and challenge of high-throughput sequencing of the antibody repertoire. Nat. Biotechnol. 32, 158–168 (2014).
11.  Guthals, A., Clauser, K. R. & Bandeira, N. Shotgun Protein Sequencing with Meta-contig Assembly * □. 1084–1096 (2012) doi:10.1074/mcp.M111.015768.
12.  Guthals, A., Clauser, K. R., Frank, A. M. & Bandeira, N. Sequencing-Grade De novo Analysis of MS / MS Triplets ( CID / HCD / ETD ) From Overlapping Peptides. (2013) doi:10.1021/pr400173d.
13.  Guthals, A. et al. De Novo MS / MS Sequencing of Native Human Antibodies De Novo MS / MS Sequencing of Native Human Antibodies. (2016) doi:10.1021/acs.jproteome.6b00608.
14.  Lebedev, A., Damoc, E., Makarov, A. & Samguina, T. Winning The Last Battle Against Edman Degradation : Reliable Leucine / Iso-leucine Differentiation In Peptide Sequencing Using an Orbitrap Fusion Mass Spectrometer. 2–8.
15.  Lebedev, A. T., Damoc, E., Makarov, A. A. & Samgina, T. Y. Discrimination of leucine and isoleucine in peptides sequencing with orbitrap fusion mass spectrometer. Anal. Chem. 86, 7017–7022 (2014).
16.  Liu, X., Han, Y., Yuen, D. & Ma, B. Automated protein ( re ) sequencing with MS / MS and a homologous database yields almost full coverage and accuracy. 25, 2174–2180 (2009).
17.  M. Christopher, A. M. L. S. HHS Public Access. Physiol. Behav. 176, 100–106 (2016).
18.  Muth. DeNovoGUI: An open source graphical user interface for de novo sequencing of tandem mass spectra. J. Proteome Res. 13, 1143–1146 (2014).
19.  Nakamura, T., Nagaki, H., Ohki, Y. & Kinoshita, T. Differentiation of leucine and isoleucine residues in peptides by consecutive reaction mass spectrometry. Anal. Chem. 62, 311–3 (1990).
20.  Nuno Bandeira,1 Victoria Pham,2 Pavel Pevzner,1,* David Arnott, 2 and Jennie R Lill2. Beyond Edman Degradation: Automated De novo Protein Sequencing of Monoclonal Antibodies. 26, 1336–1338 (2010).
21.  Olafsen, T., Kenanova, V. E. & Wu, A. M. Antibody Engineering. Antib. Eng. 2, 69–84 (2010).
22.  Pham, V. et al. De novo proteomic sequencing of a monoclonal antibody raised against OX40 ligand. Anal. Biochem. 352, 77–86 (2006).
23.  Pisupati, K. et al. A Multidimensional Analytical Comparison of Remicade and the Biosimilar Remsima. Anal. Chem. 89, 4838–4846 (2017).
24.  Poston, C. N. et al. A quantitative tool to distinguish isobaric leucine and isoleucine residues for mass spectrometry-based de novo monoclonal antibody sequencing. J. Am. Soc. Mass Spectrom. 25, 1228–1236 (2014).
25.  Qeli, E. & Ahrens, C. H. PeptideClassifier for protein inference and targeted quantitative proteomics. Nat. Biotechnol. 28, 647–650 (2010).
26.  Rickert, K. W. et al. Combining phage display with de novo protein sequencing for reverse engineering of monoclonal antibodies. MAbs 8, 501–512 (2016).
27.  Samgina, T. Y. et al. Mass spectrometric de novo sequencing of natural non-tryptic peptides: Comparing peculiarities of collision-induced dissociation (CID) and high energy collision dissociation (HCD). Rapid Commun. Mass Spectrom. 28, 2595–2604 (2014).
28.  Sample, L. C. Antibody Sequencing Coverage. 2017.
29. Savidor, A. et al. Database Independent Protein Sequencing ( DiPS ) enables full-length de-novo protein and antibody sequence determination Running title : DiPS enables protein sequence determination Abbreviations pTA Peptide Tag Assembler DiPS Database Independent Protein . (2017).
30.  Sen, K. I. et al. Automated Antibody De Novo Sequencing and Its Utility in Biopharmaceutical Discovery. J. Am. Soc. Mass Spectrom. 28, 803–810 (2017).
31.  Shao, C., Zhang, Y. & Sun, W. Statistical characterization of HCD fragmentation patterns of tryptic peptides on an LTQ Orbitrap Velos mass spectrometer. J. Proteomics 109, 26–37 (2014).
32.  Soltwisch, J. & Dreisewerd, K. Discrimination of isobaric leucine and isoleucine residues and analysis of post-translational modifications in peptides by MALDI in-source decay mass spectrometry combined with collisional cooling. Anal. Chem. 82, 5628–5635 (2010).
33.  Sousa, E. et al. Primary sequence determination of a monoclonal antibody against α-synuclein using a novel mass spectrometry-based approach. Int. J. Mass Spectrom. 312, 61–69 (2012).
34.  Squire, N. L., Beranov??, ????rka & Wesdemiotis, C. Tandem mass spectrometry of peptides. III???differentiation between leucine and isoleucine based on neutral losses. J. Mass Spectrom. 30, 1429–1434 (1995).
35.  Tang et al., 2005. NIH Public Access. Bone 23, 1–7 (2008).
36.  Tang, W. H., Kil, Y. J., Bern, M., Nayak, S. & Igm, A. Automatic End-to-End De Novo Sequencing ( including I / L ) of Antibodies with EThcD Fragmentation ® Features Byologic ® Features Byologic ® Features Byologic Leucine / Isoleucine Determination Workflow NISTmAb ® Features Byologic Discussion and Conclusions IgG / IgM Glycosylation Experimental Methods. 26, 103362 (2017).
37.  Tanokura, M. Supplemental materials. J. Biochem. 94, 62 (1983).
38.  Tran, N. H. et al. Complete de Novo Assembly of Monoclonal Antibody Sequences. Sci. Rep. 6, 1–10 (2016).
39.  Vorobyev, A., Hamidane, H. Ben & Tsybin, Y. O. Electron Capture Dissociation Product Ion Abundances at the X Amino Acid in RAAAA-X-AAAAK Peptides Correlate with Amino Acid Polarity and Radical Stability. J. Am. Soc. Mass Spectrom. 20, 2273–2283 (2009).
40.  Wang, R. Protein De novo Sequencing by. (2016).
41.  Xiao, Y., Vecchi, M. M. & Wen, D. Distinguishing between Leucine and Isoleucine by Integrated LC-MS Analysis Using an Orbitrap Fusion Mass Spectrometer. Anal. Chem. 88, 10757–10766 (2016).
42.  Zhokhov, S. S., Kovalyov, S. V., Samgina, T. Y. & Lebedev, A. T. An EThcD-Based Method for Discrimination of Leucine and Isoleucine Residues in Tryptic Peptides. J. Am. Soc. Mass Spectrom. (2017) doi:10.1007/s13361-017-1674-3.
43.  Zubarev, R. Protein primary structure using orthogonal fragmentation techniques in Fourier transform mass spectrometry. Expert Rev. Proteomics 3, 251–261 (2006).